Clinical trials for Suicide

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Suicide. For all clinical trials, go to clinical trials search

This list shows clinical trials for Suicide

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Suicide
Title Recruitment status Location
A Multicenter, Randomized, Double-blind, Active-Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients with Treatment Resistant Major Depression Recruiting United Kingdom
Understanding the impact of Ulcerative Colitis and its associated disease burden on patients Recruiting United Kingdom
A randomised, 6-week, multicentre, open-label, rater-blinded parallelgroup study comparing Quetiapine extended release monotherapy and augmentation with Lithium augmentation in patients with Treatment Resistant Depression - RUBY Not Recruiting United Kingdom
The Efficacy of Therapeutic Treatments in Chronic Anorexia Nervosa Not recruiting United Kingdom
Long-Term Safety and Tolerability of BMS-820836 in the treatment of patients with treatment Resistant Major Depression Not Recruiting United Kingdom
A study of the new pharmaceutical LuAA21004 in comparison to agomelatine in adults suffering from major depression who did not respond well to previous medication. Not Recruiting United Kingdom
Promotion of self-help strategies for sub-threshold depression: An e-mental health randomised controlled trial Not recruiting United Kingdom
Efficacy and Safety of Fixed doses of BMS 820836 in the Treatment of Patients with Treatment Resistant Major Depression Not Recruiting United Kingdom
A randomised, 6-week, multicentre, open-label, rater-blinded parallelgroup study comparing Quetiapine extended release monotherapy and augmentation with Lithium augmentation in patients with Treatment Resistant Depression - RUBY Not Recruiting United Kingdom
Randomised, double-blind, parallel-group, placebo-controlled, and active referenced study of Lu AA34893 to evaluate the efficacy and safety of three doses Lu AA34893 and quetiapine versus placebo in the treatment of depression in patients with Bipolar I or II Disorder Not Recruiting United Kingdom

Page last reviewed: 09/02/2015

Next review due: 01/02/2018